Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IOWA PHARMACISTS ASSN. JOINS KANSAS & NEBRASKA IN REGIONAL GROUP-BUYING PROGRAM

Executive Summary

IOWA PHARMACISTS ASSN. JOINS KANSAS & NEBRASKA IN REGIONAL GROUP-BUYING PROGRAM that is growing in the Midwest under the aegis of PACE Shared Services Group of Sioux Falls, S.D. The Iowa Pharmacists Assn., whose board has approved establishment of a new for-profit corporation to develop a community pharmacy cooperative buying group, reports that 30% to 40% of lowa's 800 pharmacies have indicated an intent to participate in the program. The Kansas Pharmacy Service Corp. of Topeka, organized by the Kansas Pharmacists Assn., earlier estimated a potential membership of 500 pharmacies in its group purchasing program affiliated with PACE. In addition, the Nebraska Pharmacists Assn. has signed a letter of intent to join the alliance, and pharmacy groups in several other midwestern states are contemplating affiliation. Pharmacy Business & Services Inc., the tentative working-name for the Iowa group, has sent a letter of intent to work with the PACE operation. The Iowa assn.'s board is forming a steering cmte. of five or six pharmacists to propose initiation fees, investigate whether the lowa group should be served by a single whslr. or multiple whslrs., and devise specifications that whslrs. and mfrs. will be asked to meet when submitting bids. The board is headed by the assn.'s President Sue Yeakel. In authorizing formation of the wholly-owned subsidiary of the lowa assn., the Board of Trustees said it intends to provide community pharmacy owners with "a system of product acquisition which enables them to purchase legend drugs at lower cost in order to improve their competitive posture in the retail pharmacy marketplace." The assn.'s Professional Affairs Director Allan Zaenger added: "There is increasing evidence that the environment is conducive for development of a new mechanism which enables community pharmacists to exercise collective strength in purchasing drug products rather than being resigned to accepting the seller's offers when acquiring inventory of drug products." PACE, a nonprofit subsidiary of Presentation Health Systems Inc., is part of a consortium called Healthcare Group Purchasing Assn. which administers volume-purchasing of pharmaceuticals and other hospital-related products for over 125,000 hospital beds in eight states.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel